Author: Ellen
NHK Special: “Stop Alzheimer’s Disease!” won Takayanagi Prize (Links to an external site)
In a New Approach to Fighting Disease, Helpful Genetic Mutations Are Sought (Links to an external site)
New funding speeds identification of drugs to prevent Alzheimer’s (Links to an external site)
Reclaiming the future for those affected by Alzheimer’s (Links to an external site)
Over 150 people in Montgomery are set to gather this weekend to reclaim the future for the five millions Americans suffering from Alzheimer’s. For two women in the River Region, the disease has directly impacted their lives and they’re leading the fight for a cure.
Preventing Alzheimer’s (Links to an external site)
Finding ways to diagnose and treat this devastating disease has frustrated scientists and clinicians ever since. Now the long and hard-fought campaign against Alzheimer’s has reached a potentially significant milestone: the launch of the first clinical trials to test whether new drug treatments given before dementia can prevent the disease.
Multicompany trials adapt to disciplines beyond cancer (Links to an external site)
Trials at Washington U. medical school offer hope for Alzheimer’s treatment (Links to an external site)
Unraveling Alzheimer’s mysteries in search of new treatment (Links to an external site)
Over the past several decades scientists have begun to unravel the complicated process that leads to the death of brain cells and, ultimately, the disease we call Alzheimer’s. That new understanding may lead to therapies that can halt the disease before symptoms appear and brains are irreparably damaged.
In Familial AD, Aß Production Up, Clearance Down (Links to an external site)
Researchers have long assumed that people with familial Alzheimer’s disease make too much Aβ42 in the brain, but they lacked proof. Now, in the June 12 Science Translational Medicine, researchers led by Randall Bateman at Washington University in St. Louis, Missouri, provide the first direct evidence.